Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Saraga

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Review of Gastroenterology & Hepatology|October 20, 2025
Clinical management of inflammatory bowel disease from preconception to postpartumLoren G Rabinowitz, Ajay Gade, Tina Deyhim, et al.
Expert Review of Gastroenterology & Hepatology|November 15, 2025
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel diseaseAjay Gade, Alessandra Saraga, Tina Deyhim, et al.
ACG Case Reports Journal|April 27, 2026
Sertraline-Associated Microscopic Colitis Flare in PregnancyAlessandra Saraga, Rachel Bocchino, Ajay Gade, et al.
Expert Review of Clinical Pharmacology|February 11, 2026
Therapeutic drug monitoring for de-escalating anti-tumor necrosis factor therapy in patients with inflammatory bowel diseaseAjay Gade, Alessandra Saraga, Alfonso Elosua, et al.
Inflammatory Bowel Diseases|August 26, 2025
Long-term Outcomes of Patients with Crohn's Disease Treated with RisankizumabGrace Geeganage, Ajay Gade, Alessandra Saraga, et al.
Digestive Diseases and Sciences|December 9, 2025
Proactive Compared to Reactive Therapeutic Drug Monitoring Is Associated with Less Treatment Failure in Patients with Inflammatory Bowel Disease Treated with AdalimumabAjay Gade, Alessandra Saraga, Tina Deyhim, et al.
European Journal of Gastroenterology & Hepatology|March 23, 2026
Lower drug clearance of adalimumab is associated with proactive therapeutic drug monitoring and mucosal healing in patients with inflammatory bowel diseaseTina Deyhim, Alessandra Saraga, Ajay Gade, et al.
Inflammatory Bowel Diseases|July 2, 2026
Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumabJoyce Lee, Rachel Porth, Alessandra Saraga, et al.
Journal of Clinical Medicine|January 28, 2026
Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel DiseaseAlessandra Saraga, Tina Deyhim, Ajay Gade, et al.
Digestive Diseases and Sciences|September 22, 2025
Sexual Health and STI Counseling Is Critical but Often Overlooked in IBDAlexander Goldowsky, Andrew Eidelberg, Grace Geeganage, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Review of Gastroenterology & Hepatology|October 20, 2025
Clinical management of inflammatory bowel disease from preconception to postpartumLoren G Rabinowitz, Ajay Gade, Tina Deyhim, et al.
Expert Review of Gastroenterology & Hepatology|November 15, 2025
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel diseaseAjay Gade, Alessandra Saraga, Tina Deyhim, et al.
ACG Case Reports Journal|April 27, 2026
Sertraline-Associated Microscopic Colitis Flare in PregnancyAlessandra Saraga, Rachel Bocchino, Ajay Gade, et al.
Expert Review of Clinical Pharmacology|February 11, 2026
Therapeutic drug monitoring for de-escalating anti-tumor necrosis factor therapy in patients with inflammatory bowel diseaseAjay Gade, Alessandra Saraga, Alfonso Elosua, et al.
Inflammatory Bowel Diseases|August 26, 2025
Long-term Outcomes of Patients with Crohn's Disease Treated with RisankizumabGrace Geeganage, Ajay Gade, Alessandra Saraga, et al.
Digestive Diseases and Sciences|December 9, 2025
Proactive Compared to Reactive Therapeutic Drug Monitoring Is Associated with Less Treatment Failure in Patients with Inflammatory Bowel Disease Treated with AdalimumabAjay Gade, Alessandra Saraga, Tina Deyhim, et al.
European Journal of Gastroenterology & Hepatology|March 23, 2026
Lower drug clearance of adalimumab is associated with proactive therapeutic drug monitoring and mucosal healing in patients with inflammatory bowel diseaseTina Deyhim, Alessandra Saraga, Ajay Gade, et al.
Inflammatory Bowel Diseases|July 2, 2026
Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumabJoyce Lee, Rachel Porth, Alessandra Saraga, et al.
Journal of Clinical Medicine|January 28, 2026
Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel DiseaseAlessandra Saraga, Tina Deyhim, Ajay Gade, et al.
Digestive Diseases and Sciences|September 22, 2025
Sexual Health and STI Counseling Is Critical but Often Overlooked in IBDAlexander Goldowsky, Andrew Eidelberg, Grace Geeganage, et al.
Pageof 2